Idenix (IDIX) Enters Collaboration with Janssen Pharma for DAA HCV Evaluatlion
Go back to Idenix (IDIX) Enters Collaboration with Janssen Pharma for DAA HCV Evaluatlion| Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) | Delayed: 24.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.50 | 52 Week High | $24.50 | |||
| Open | $9.18 | 52 Week Low | $4.81 | |||
| Day High | $24.50 | P/E | N/A | |||
| Day Low | $24.50 | EPS | $-0.89 | |||
| Volume | 5,300 | |||||
| Johnson & Johnson (NYSE: JNJ) | Delayed: 270.24 +2.87 (1.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $267.37 | 52 Week High | $126.07 | |||
| Open | $267.83 | 52 Week Low | $94.28 | |||
| Day High | $272.66 | P/E | 56.18 | |||
| Day Low | $267.00 | EPS | $4.81 | |||
| Volume | 6,175,740 | |||||
